The PharmaTimes Communications Team of the Year competition is the only pharma industry awards that tests the competencies and potential of communications agency teams, benchmarking talent agency side. This year sees the introduction of a new ‘Charity Challenge’, which in partnership with Beating Bowel Cancer and Bowel Cancer UK, will focus on a real life scenario for the first time.
Director of policy and communications at MSD and executive steering group member Harry Brady looks at how the PharmaTimes Marketer and Communications Team of the Year competitions have evolved to embrace the importance of cross-functional working and the value of great healthcare communications in the marketing mix.
Oversubscribed financing includes investment from Pfizer and Novartis
Strong performances for Mavenclad and Bavencio
Chairman says consumer and Rx platforms are “navigating divergent industry dynamics”
San Diego-based Ligand would acquire programmes in respiratory, oncology and CNS
Following an appeal the drug will now be available to treat ALL
Takeda has committed $100 million, including the participation in the Series A financing, to Ambys
Lawsuits allege that the company falsely and misleadingly marketed the two drugs
Diabetes segment stumbles but key brand report solid performance
British Biosimilars Association say the proposals “make no sense”
Iain will join the company on 14 Janurary 2019 and will also be appointed as an Executive Director to the Board
Agency expects close cooperation with EU and for the new Clinical Trials Regulation to apply in UK
Companies will investigate targets that historically have been a challenge for therapeutic development
Companies will leverage each others technology platforms against six initial targets
